Introduced through the Oxford Biotech Roundtable Co-Founders hub, our team has complementary expertise to drive business success.

Yug Varma, PhD (CEO) is a microbiome researcher at UCSF. Yug obtained his Ph.D. from Johns Hopkins University, and has more than 10 years of research experience with extensive skills in biochemistry and microbiology. He's passionate about bringing to market a proprietary antibacterial platform to tackle major public health concerns.

Nancy Van Prooyen, PhD (CSO) is an infectious disease and immunology expert. Nancy got her Ph.D. from Johns Hopkins University and has a strong technical background in biological research and methods development. Nancy brings a deep understanding of our technology platform for proof of concept experimental design and execution.

Maria Cho, MS (CBO) is Phi’s business and regulatory expert with over 10 years of experience in biologics testing and manufacturing. Maria's expertise is in business development, CMC and Program Management. With a MS in Biomedical Chemistry with an emphasis in Business Management, Maria supports Phi’s  licensing, business and contract negotiations for partnering and outsourced product development.